People who took Zantac (ranitidine) and were later diagnosed with cancer are filing lawsuits in federal court. Zantac lawsuits claim that Zantac and the generic version, ranitidine, had unacceptable levels of the carcinogen N-nitrosodimethylamine (NDMA).
If you or a loved one were diagnosed with cancer and you believe it was a result of taking Zantac (ranitidine), call us today.
Speak With an Experienced Lawyer at Our Firm About Zantac Litigation. Schedule a Consultation Today.
Grant & Eisenhofer P.A.’s lawyers offer free case evaluations. Our attorneys have extensive experience representing plaintiffs injured by defective drugs. Schedule a free consultation today by calling (888) 984-7988.
Zantac Litigation Overview
Zantac (ranitidine) is a medication designed to treat heartburn and acid reflux. The drug was approved by the FDA in 1983, and just five years later, became the best-selling drug in the world.
In September 2019, however, Zantac manufacturers began recalling Zantac and generic or over the counter ranitidine medicines. This recall was due to the presence of N-nitrosodimethylamine (NDMA) in samples of Zantac. NDMA is a carcinogen, known to cause many types of cancer after long-term, high-dose exposure. By April 2020, the FDA ordered all Zantac products completely taken off the market.
Many studies have demonstrated a link between the NDMA in Zantac and cancer since as early as the 1980s. There is also an overabundance of evidence that allegedly shows manufacturers of Zantac concealed the cancer link from millions of people who took the drug for a number of issues. This deception occurred as companies accumulated substantial profits from Zantac, making it the first drug ever to generate $1 billion in sales.
A recent study published in October 2020 suggests that levels of NDMA in Zantac may increase due to heat and humidity. The study analyzed NDMA levels in two Zantac tablets from two different brands that were stored at 104 degrees Fahrenheit and 75% relative humidity for 8 weeks. NDMA levels significantly increased to up to 116 parts per million—well beyond the FDA-imposed limit of .32 parts per million.
Frequently Asked Questions About Zantac Litigation
Who is at Risk for Developing Cancer from Taking Zantac?
Patients who took the antacid over a long period of time may be at risk for developing certain cancers. Did you take 300mg/week of Zantac (ranitidine) for at least five years? If you did, and later received a diagnosis of one of the cancers listed below, call our law firm for a free consultation.
What Kinds of Cancer Does Zantac Cause?
Zantac (ranitidine) may cause several different types of cancer in adults and children, including:
- Liver cancer
- Bladder cancer
- Colorectal cancer
- Prostate cancer
- Esophageal/Throat/Nasal cancer
- Stomach cancer
- Brain cancer
- Kidney (renal) cancer
- Pancreatic cancer
- Lung cancer
- Testicular cancer
What is the Status of the Current Zantac Lawsuit?
Many injured plaintiffs from around the country are filing lawsuits in federal court. The lawsuits are being consolidated and coordinated in the Southern District of Florida before The Honorable Robin L. Rosenberg (MDL No. 2924 – In re Zantac (Ranitidine) Products Liability Litigation). In addition to the cases in federal court, there are also cases that have been filed in state courts throughout the country. Thousands more individuals may file lawsuits in the future in these coordinated proceedings. The patients that these lawsuits are filed on behalf of, suffered injuries or died due to cancer following their chronic use of Zantac and/or ranitidine. These cancers include:
Am I Eligible to File a Zantac Cancer Lawsuit?
If you believe your cancer diagnosis was a result of taking Zantac (ranitidine), call the experienced attorneys at Grant & Eisenhofer today at (888) 984-7988 for a confidential consultation. It’s not too late to investigate your potential claim.